Amgen, Xencor In Development Deal
socalTECH
JANUARY 6, 2011
Thousand Oaks-based Amgen , and Monrovia-based Xencor said Thursday that the two firms are in a co-development dual around a new novel antibody for treating autoimmune diseases. The deal also includes tiered royalties on future sales of XmAb5871. READ MORE>>.
Let's personalize your content